Jun 12, 2014
Knutsford, UK — The Fishawack Group of Companies is pleased to announce the appointment of John Handley to the role of Chairman of the Fishawack Group of Companies. Fishawack is one of the leading independent medical communications specialists, partnering with global and regional pharmaceutical, biotechnology and medical device clients. Fishawack’s team of over 220 are based at offices in the UK, the US and Switzerland, all strategic locations for the pharma and biopharma industries.
John Handley brings a wide range of expertise to the role, including extensive experience of chairing companies backed by private equity investors. He has a track record of creating value in businesses and negotiating successful acquisitions, and also lectures on behalf of the British Venture Capital Association. In addition, John’s previous and current roles equip him to support the continued expansion of Fishawack’s international business across multiple locations, and to contribute to the strategic discussions essential to maintaining the Group’s successful growth.
“We are delighted that John is taking on the role of Chairman at Fishawack,” said Oliver Dennis, CEO of the Fishawack Group. “It has been a long search to find the right person, someone with the right experience of a buy and build strategy and international expansion, but who could rapidly understand the medical communications business and collaborate with an ambitious and dynamic management team. We are very excited to be working with John and to continue to develop the Fishawack Group.”
“I have been impressed by the rate of growth that the Fishawack team has achieved over the past few years,” commented John Handley. “This has been both through acquisition and organically within the individual companies, but with effective consolidation and without losing the Group’s specialist focus. I can see the further potential that the management team has identified in their strategic growth plan and anticipate a productive relationship creating further value in the business.”
“We always like to partner with independently minded chairs who have a proven record of adding value,” explained Garrett Curran of Fishawack’s private equity backer, Growth Capital Partners. “We are looking forward both to John joining the board, and to building on the great relationship we have established with the Fishawack management team since we invested in the Group around a year ago.”